These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. BAFF and BAFF-R of peripheral blood and spleen mononuclear cells in idiopathic thrombocytopenic purpura. Zhou Z; Chen Z; Li H; Chen X; Xu J; Gu D; Du W; Zheng C; Zhang L; Huang Y; Ren Q; Yang R Autoimmunity; 2009 Feb; 42(2):112-9. PubMed ID: 19005881 [TBL] [Abstract][Full Text] [Related]
5. BAFF and APRIL expression in B-cell chronic lymphocytic leukemia: correlation with biological and clinical features. Bojarska-Junak A; Hus I; Chocholska S; Wasik-Szczepanek E; Sieklucka M; Dmoszyńska A; Roliński J Leuk Res; 2009 Oct; 33(10):1319-27. PubMed ID: 19395025 [TBL] [Abstract][Full Text] [Related]
6. Serum angiogenin is not elevated in patients with early B-cell chronic lymphocytic leukemia but is prognostic factor for disease progression. Molica S; Vitelli G; Levato D; Giannarelli D; Vacca A; Cuneo A; Ribatti D; Digiesi G Eur J Haematol; 2004 Jul; 73(1):36-42. PubMed ID: 15182336 [TBL] [Abstract][Full Text] [Related]
7. Serum insulin-like growth factor is not elevated in patients with early B-cell chronic lymphocytic leukemia but is still a prognostic factor for disease progression. Molica S; Vitelli G; Mirabelli R; Digiesu G; Giannarelli D; Cuneo A; Ribatti D; Vacca A Eur J Haematol; 2006 Jan; 76(1):51-7. PubMed ID: 16343271 [TBL] [Abstract][Full Text] [Related]
8. BAFF is elevated in serum of patients with Wegener's granulomatosis. Krumbholz M; Specks U; Wick M; Kalled SL; Jenne D; Meinl E J Autoimmun; 2005 Dec; 25(4):298-302. PubMed ID: 16242914 [TBL] [Abstract][Full Text] [Related]
9. Elevated B cell-activating factor of the tumour necrosis factor family in coeliac disease. Fabris M; Visentini D; De Re V; Picierno A; Maieron R; Cannizzaro R; Villalta D; Curcio F; De Vita S; Tonutti E Scand J Gastroenterol; 2007 Dec; 42(12):1434-9. PubMed ID: 17852877 [TBL] [Abstract][Full Text] [Related]
10. Circulating proangiogenic cytokines and angiogenesis inhibitor endostatin in untreated patients with chronic lymphocytic leukemia. Gora-Tybor J; Blonski JZ; Robak T Mediators Inflamm; 2003 Jun; 12(3):167-71. PubMed ID: 12857600 [TBL] [Abstract][Full Text] [Related]
11. Immunophenotypic features distinguishing familial chronic lymphocytic leukemia from sporadic chronic lymphocytic leukemia. Ahmad E; Steinberg SM; Goldin L; Hess CJ; Caporaso N; Kreitman RJ; Wiestner A; Wilson W; White T; Marti G; Stetler-Stevenson M Cytometry B Clin Cytom; 2008 Jul; 74(4):221-6. PubMed ID: 18431797 [TBL] [Abstract][Full Text] [Related]
12. Elevated serum B-Lymphocyte activating factor (BAFF) in chronic hepatitis C virus infection: association with autoimmunity. Toubi E; Gordon S; Kessel A; Rosner I; Rozenbaum M; Shoenfeld Y; Zuckerman E J Autoimmun; 2006 Sep; 27(2):134-9. PubMed ID: 17029886 [TBL] [Abstract][Full Text] [Related]
13. High-level serum B-cell activating factor and promoter polymorphisms in patients with idiopathic thrombocytopenic purpura. Emmerich F; Bal G; Barakat A; Milz J; Mühle C; Martinez-Gamboa L; Dörner T; Salama A Br J Haematol; 2007 Jan; 136(2):309-14. PubMed ID: 17156395 [TBL] [Abstract][Full Text] [Related]
14. Circulating endothelial cells in patients with chronic lymphocytic leukemia. Go RS; Jobe DA; Asp KE; Callister SM; Mathiason MA; Meyer LA; Bottner WA; Cole CE; Farnen JP; Frisby KA Ann Hematol; 2008 May; 87(5):369-73. PubMed ID: 18193423 [TBL] [Abstract][Full Text] [Related]
15. Clinical features and outcome of Chinese patients with monoclonal B-cell lymphocytosis. Xu W; Li JY; Wu YJ; Cao X; Fan L; Qiao C; Liu Q; Yao L; Miao KR Leuk Res; 2009 Dec; 33(12):1619-22. PubMed ID: 19250675 [TBL] [Abstract][Full Text] [Related]
16. The significance of soluble HLA-G plasma levels as well as messenger HLA-G for B-cell chronic lymphocytic leukemia (B-CLL). Giannopoulos K; Schmitt M; Kowal M; Własiuk P; Bojarska-Junak A; Roliński J; Dmoszyńska A Leuk Res; 2008 Dec; 32(12):1815-9. PubMed ID: 18499249 [TBL] [Abstract][Full Text] [Related]
17. Elevated serum BAFF levels in patients with autoimmune hepatitis. Migita K; Abiru S; Maeda Y; Nakamura M; Komori A; Ito M; Fujiwara S; Yano K; Yatsuhashi H; Eguchi K; Ishibashi H Hum Immunol; 2007 Jul; 68(7):586-91. PubMed ID: 17584580 [TBL] [Abstract][Full Text] [Related]
18. Increased serum levels of B cell activating factor (BAFF) in subsets of patients with idiopathic inflammatory myopathies. Krystufková O; Vallerskog T; Helmers SB; Mann H; Putová I; Belácek J; Malmström V; Trollmo C; Vencovsky J; Lundberg IE Ann Rheum Dis; 2009 Jun; 68(6):836-43. PubMed ID: 18628284 [TBL] [Abstract][Full Text] [Related]
19. Autoimmune cytopenia does not predict poor prognosis in chronic lymphocytic leukemia/small lymphocytic lymphoma. Kyasa MJ; Parrish RS; Schichman SA; Zent CS Am J Hematol; 2003 Sep; 74(1):1-8. PubMed ID: 12949883 [TBL] [Abstract][Full Text] [Related]
20. Serum BAFF expression in patients with myasthenia gravis. Kim JY; Yang Y; Moon JS; Lee EY; So SH; Lee HS; Park KD; Choi YC J Neuroimmunol; 2008 Aug; 199(1-2):151-4. PubMed ID: 18586330 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]